Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2021-05-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details specific amendments to the terms of the convertible bonds, such as the conversion price adjustment period. In the context of Korean financial filings (DART system), this is a 'Major Report' (주요사항보고서) concerning capital financing activities. Since it specifically details the issuance and terms of convertible bonds (a form of financing), it falls under the 'Capital/Financing Update' category.
2021-05-28 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing titled '전환사채권 발행결정' (Decision to Issue Convertible Bonds) and '정정신고(보고)' (Correction Report). It details specific financial terms, including the purpose of funds, maturity dates, interest payment methods, and conversion price adjustments for convertible bonds issued by Cellumed. This is a standard corporate disclosure regarding financing activities and capital structure changes, which falls under the 'Capital/Financing Update' category.
2021-05-27 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details specific changes to the bond terms, such as maturity dates, interest payment schedules, call/put option conditions, and payment dates. In the context of financial filings, this is a regulatory disclosure of a material change to a financing instrument. Since it is a formal regulatory filing detailing capital structure changes and financing terms, it falls under the 'Capital/Financing Update' category.
2021-05-27 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company Cellumed, covering the period from January 1, 2021, to March 31, 2021. It contains detailed financial statements, management discussions, and corporate information. It is a formal regulatory filing submitted to the Financial Services Commission and the Korea Exchange. Based on the definition, this is an Interim/Quarterly Report (IR). Q1 2021
2021-05-18 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange (KRX) by Cellumed. It details the decision to issue convertible bonds (전환사채권 발행결정), including terms such as interest rates, conversion prices, call/put options, and the use of proceeds. This is a formal regulatory filing regarding capital structure changes and financing, which falls under the 'Share Issue/Capital Change' category as it relates to the issuance of convertible securities.
2021-05-17 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the bond, including interest rates, conversion prices, call/put options, and the use of proceeds. This falls under the category of capital and financing updates for the company.
2021-05-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.